2A60.40

ICD-11 MMS 2026-01

Transient abnormal myelopoiesis

Description

A myeloid proliferation occurring in newborns with Down syndrome. It is clinically and morphologically indistinguishable from acute myeloid leukaemia and is associated with GATA1 mutations. The blasts display morphologic and immunophenotypic features of megakaryocytic lineage. In the majority of patients the myeloid proliferation undergoes spontaneous remission.

Index terms

  • Transient abnormal myelopoiesis

Exclusions from above levels

  • 2E03 – Malignant neoplasm metastasis in bone or bone marrow
  • http://id.who.int/icd/entity/501778925 – Malignant neoplasm metastasis in lymph nodes
  • http://id.who.int/icd/entity/97145147 – Malignant neoplasm metastasis in thymus gland

Sibling codes

  • 2A60.41 – Myeloid leukaemia associated with Down syndrome
  • 2A60.4Y – Other specified myeloid proliferation associated with Down syndrome
  • 2A60.4Z – Myeloid proliferation associated with Down syndrome, unspecified

Foundation entity

Transient abnormal myelopoiesis – http://id.who.int/icd/entity/2082163425

Allowed postcoordination axes

Part of: 2A60.4: Myeloid proliferation associated with Down syndrome › 2A60: Acute myeloid leukaemias and related precursor neoplasms › 02: Neoplasms